News archive
https://amr-accelerator.eu/wp-content/uploads/2021/12/UNITE4TB_News_5000x4000px.png
4000
5000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2021-07-15 19:20:102021-12-16 09:04:2415/07/21 – Launch of UNITE4TB partnership
https://amr-accelerator.eu/wp-content/uploads/2021/12/TRiC_TB_News_5000x4000px.png
4000
5000
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2021-07-06 11:25:392023-04-20 10:29:1606/07/21 – BioVersys pipeline presentations at ECCMID July 9-12, 2021
https://amr-accelerator.eu/wp-content/uploads/2021/05/gna-now-open-call-2.png
300
455
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2021-05-10 11:40:412021-07-15 20:08:0910/05/21 – Open Call: Apply now to join the GNA NOW Consortium
https://amr-accelerator.eu/wp-content/uploads/2022/12/COMBINE_Interview.png
250
800
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2021-05-09 09:43:282025-11-12 14:18:21Interview with Anders Karlén: COMBINE Project Coordinator, Uppsala University
https://amr-accelerator.eu/wp-content/uploads/2021/04/GNA-NOW_Interview.jpg
250
800
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2021-04-15 10:09:392025-11-12 14:19:55Interview with Eric Bacqué: GNA NOW Project Lead, Evotec
https://amr-accelerator.eu/wp-content/uploads/2021/03/amr-accelerator-logo.png
300
455
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2021-03-25 11:53:282021-07-15 20:08:2825/03/21 – Tackling antibiotic resistance together
https://amr-accelerator.eu/wp-content/uploads/2022/12/AB-Direct-e1716892977411.png
200
600
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2021-02-01 11:42:352023-04-20 10:32:1802/21 -Launch of AB-Direct Phase 1 study
https://amr-accelerator.eu/wp-content/uploads/2021/01/TRIC-TB_Logo.jpg
300
455
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2021-01-12 14:26:332021-07-15 20:08:4912/01/21 – BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BVL-GSK098
https://amr-accelerator.eu/wp-content/uploads/2020/07/Annual-meeting-image.png
1440
2560
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2020-06-24 12:10:182023-04-20 10:24:5324/06/20 – Successful First Annual Meeting for IMI project GNA NOW
https://amr-accelerator.eu/wp-content/uploads/2020/07/Tric-TB_logo.png
285
489
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2020-06-23 14:43:012023-04-20 10:23:1423/06/20 – BioVersys receives QIDP designation for BVL-GSK098 and ETH
https://amr-accelerator.eu/wp-content/uploads/2019/05/COMBINE_logo-e1647497540928.jpg
435
1360
Tolga
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
Tolga2020-03-11 14:12:092022-03-17 07:23:5811/03/20 – COMBINE Call for preclinical and clinical data sets
https://amr-accelerator.eu/wp-content/uploads/2020/01/ERA4TB_logotipos_hq-2.png
150
680
h.genrich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
h.genrich2020-01-29 16:29:512021-07-15 20:11:3629/01/20 – ERA4TB, the new IMI project to accelerate the fight against tuberculosis